Skip to main navigation Skip to search Skip to main content

Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia

  • Puja J. Umaretiya
  • , Victoria B. Koch
  • , Yael Flamand
  • , Rahela Aziz-Bose
  • , Lenka Ilcisin
  • , Ariana Valenzuela
  • , Peter D. Cole
  • , Lisa M. Gennarini
  • , Justine M. Kahn
  • , Kara M. Kelly
  • , Thai Hoa Tran
  • , Bruno Michon
  • , Jennifer J.G. Welch
  • , Joanne Wolfe
  • , Lewis B. Silverman
  • , Kira Bona
  • Dana-Farber Cancer Institute
  • Boston Children's Hospital
  • Harvard University
  • Brigham and Women’s Hospital
  • Rutgers - The State University of New Jersey, New Brunswick
  • Albert Einstein College of Medicine
  • Columbia University
  • University of Montreal
  • Centre de Recherche du Centre Hospitalier de l'Université Laval (CRCHUL)
  • Brown University

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Background: Parent psychological distress during childhood cancer treatment has short- and long-term implications for parent, child, and family well-being. Identifying targetable predictors of parental distress is essential to inform interventions. We investigated the association between household material hardship (HMH), a modifiable poverty-exposure defined as housing, food, or utility insecurity, and severe psychological distress among parents of children aged 1-17 years with acute lymphoblastic leukemia (ALL) enrolled on the multicenter Dana-Farber ALL Consortium Trial 16-001. Methods: This was a secondary analysis of parent-reported data. Parents completed an HMH survey within 32 days of clinical trial enrollment (T0) and again at 6 months into therapy (T1). The primary exposure was HMH at T0 and primary outcome was severe parental distress at T0 and T1, defined as a score greater than or equal to 13 on the Kessler-6 Psychological Distress Scale. Multivariable models were adjusted for ALL risk group and single parent status. Results: Among 375 evaluable parents, one-third (32%; n ¼ 120/375) reported HMH at T0. In multivariable analyses, T0 HMH was associated with over twice the odds of severe psychological distress at T0 and T1 HMH was associated with over 5 times the odds of severe distress at T1. Conclusions: Despite uniform clinical trial treatment of their children at well-resourced pediatric centers, HMH-exposed parents—compared with unexposed parents—experienced statistically significantly increased odds of severe psychological distress at the time of their child’s leukemia diagnosis, which worsened 6 months into therapy. These data identify a high-risk parental population who may benefit from early psychosocial and HMH-targeted interventions to mitigate disparities in well-being.

Original languageEnglish
Pages (from-to)1179-1187
Number of pages9
JournalJournal of the National Cancer Institute
Volume115
Issue number10
DOIs
StatePublished - Oct 1 2023

Fingerprint

Dive into the research topics of 'Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Cite this